What's New

  • News
  • HanaVax Inc. has raised funds from Fast Track Initiative, Inc., SMBC Venture Capital, Nishihara Shokai Co., Ltd. and Kondo Cotton Spinning Co., Ltd..
  • News
  • President & CEO of our company attended 2018 BIO International Convention at Boston. Partnering meeting with Pharma showing interest in our platform technologies and lead product.
  • News
  • Based on our research team latest finding; a novel patent for vaccine development will be drafted.
  • News
  • Recent Publications

    Nanogel-based nasal vaccines for infectious and lifestyle-related diseases.
    Azegami T, Yuki Y, Nakahashi R, Itoh H, Kiyono H.
    Mol Immunol. 2017 Oct 30. pii: S0161-5890(17)30551-5.
    doi:10.1016/j.molimm.2017.10.022. [Epub ahead of print]

    Development of a nanogel-based nasal vaccine as a novel antigen delivery system.
    Nakahashi-Ouchida R, Yuki Y, Kiyono H.
    Expert Rev Vaccines. 2017 Oct 27:1-10.
    doi: 10.1080/14760584.2017.1395702. [Epub ahead of print]